Litcius/Paper detail

OA22.04 BRIGHTSTAR Local Consolidative Therapy with Brigatinib in Tyrosine Kinase Inhibitor-Naïve ALK-Rearranged Metastatic NSCLC

Yasir Y. Elamin, S. Gandhi, Mohammed Saad, Sadiq Rehmani, Mara B. Antonoff, Don L. Gibbons, Xiuning Le, Marcelo V. Negrão, Vincent K. Lam, Mehmet Altan, J. Tu, Carl M. Gay, Lauren A. Byers, Tina Cascone, George R. Blumenschein, Joe Y. Chang, Ara A. Vaporciyan, Zhongxing Liao, Stephen G. Swisher, Jianhua Yin, K. Park, P. Zhang, Jia Wu, John V. Heymach

2023Journal of Thoracic Oncology14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTyrosine-kinase inhibitorAcquired resistanceTyrosine kinaseOncologyCancer researchDiseaseInternal medicineResidualCancerAlgorithmReceptorComputer scienceLung Cancer Treatments and MutationsGastric Cancer Management and OutcomesColorectal Cancer Treatments and Studies